RT @EARL_Med_Tw: さらにASPREE trialの3つ目の解析.アスピリンは死亡,認知症,身体機能障害の複合アウトカムを減少させない.(N Engl J Med 2018, Sep16) https://t.co/GP3MwyoNdL 以上、3つの報告から、高…
RT @juliomcrosa: EFECTO DE LA ASPIRINA EN LA SUPERVIVENCIA LIBRE DE DISCAPACIDAD EN ANCIANOS SANOS (¿Cae un mito?) https://t.co/kGh0nJEpLT
さらにASPREE trialの3つ目の解析.アスピリンは死亡,認知症,身体機能障害の複合アウトカムを減少させない.(N Engl J Med 2018, Sep16) https://t.co/GP3MwyoNdL 以上、3つの報告から、高齢者の一次予防のアスピリン投与に一利なく、出血、全原因死亡、癌関連死が増加 https://t.co/cVvYgyDlEG
RT @Gill_Livingston: Great trial. Huge numbers, long follow up and small loss. Low dose aspirin in healthy older people does not reduce sub…
【PCPに飲めと云われて、毎日飲んでるんだが・・・笑】
RT @Steph_Achenbach: 3rd recent “Nail in the Coffin“ for aspirin in primary prevention? After ARRIVE in 12 546 moderate risk individuals, A…
RT @EricTopol: When low-dose aspirin is not only a bust, but is associated with higher all-cause mortality, #cancer, and more bleeding in h…
RT @nicolasrennamd: 3 ° gol en contra para la aspirina en la prevención primaria? Primero ARRIVE con 12546p de riesgo moderado, ASCEND con…
RT @m_schefft: Another important example of medical reversal after a large prospective RCT. More work for the de-implementation scientists.…
Real important Australian led study
RT @m_schefft: Another important example of medical reversal after a large prospective RCT. More work for the de-implementation scientists.…
RT @EricTopol: When low-dose aspirin is not only a bust, but is associated with higher all-cause mortality, #cancer, and more bleeding in h…
RT @EricTopol: When low-dose aspirin is not only a bust, but is associated with higher all-cause mortality, #cancer, and more bleeding in h…
RT @m_schefft: Another important example of medical reversal after a large prospective RCT. More work for the de-implementation scientists.…
RT @m_schefft: Another important example of medical reversal after a large prospective RCT. More work for the de-implementation scientists.…
RT @EricTopol: When low-dose aspirin is not only a bust, but is associated with higher all-cause mortality, #cancer, and more bleeding in h…
Should we stop aspirin same time as #statin? #StopPolypharmacy
RT @m_schefft: Another important example of medical reversal after a large prospective RCT. More work for the de-implementation scientists.…
RT @EricTopol: When low-dose aspirin is not only a bust, but is associated with higher all-cause mortality, #cancer, and more bleeding in h…
RT @EricTopol: When low-dose aspirin is not only a bust, but is associated with higher all-cause mortality, #cancer, and more bleeding in h…
RT @DrDrugExpert: An Aspirin a day does NOT keep the doctor away in healthy elderly. Actually the risks of aspirin related bleeding and sid…
Another important example of medical reversal after a large prospective RCT. More work for the de-implementation scientists. @QuinonezRicardo @safelydoingless @MattDavidGarber
An Aspirin a day does NOT keep the doctor away in healthy elderly. Actually the risks of aspirin related bleeding and side effects outweigh the benefits in these patients. #NEWS #Aspirin #Medical #Pharmacist #patientsafety #PatientCare Read study here: h
RT @Drroxmehran: No benefit for ASA in healthy elderly ASPREE investigators https://t.co/YIhJpq5fbT
RT @groopman: Another important finding that argues against coercive quality metrics—every study limitations, and risk/benefit analysis has…
健康な高齢者が毎日アスピリンを100 mg 服用しても、将来の死亡や認知症、身体障害を予防出来ず。それどころか大出血のリスクが高まる。Effect of Aspirin on Disability-free Survival in the Healthy Elderly https://t.co/wJfDqYgoMQ
RT @Steph_Achenbach: 3rd recent “Nail in the Coffin“ for aspirin in primary prevention? After ARRIVE in 12 546 moderate risk individuals, A…
RT @Steph_Achenbach: 3rd recent “Nail in the Coffin“ for aspirin in primary prevention? After ARRIVE in 12 546 moderate risk individuals, A…
RT @OnLTCC: Effect of Aspirin on Disability-free Survival in the Healthy Elderly | NEJM https://t.co/CFH7TYmJHU ASPREE (ASPirin in Reducing…
RT @ryoma_tanaka: アスピリンについてのスタディーが3つNEJMに発表されましたね。 出血が増えて悪性疾患が増えて心血管疾患は減らなくて、死亡リスクは増えるという何だか大変な結果になっています。 https://t.co/tdsfmj8miC https://t…
RT @Steph_Achenbach: 3rd recent “Nail in the Coffin“ for aspirin in primary prevention? After ARRIVE in 12 546 moderate risk individuals, A…
RT @ryoma_tanaka: アスピリンについてのスタディーが3つNEJMに発表されましたね。 出血が増えて悪性疾患が増えて心血管疾患は減らなくて、死亡リスクは増えるという何だか大変な結果になっています。 https://t.co/tdsfmj8miC https://t…
RT @jfk_tigers: 一次予防でアスピリンを服用させる意味なんてあるの?、って常々思っていたけど、これではっきりとしたのかもしれません。 https://t.co/1c45pLI1kh
「毎日の低用量 #アスピリン で延命」単純明快なASPREE試験が失敗。出血だけでなく癌死も多かった。MonashのMcNeil :「有益部分群もありません。ただし、癌リスクには留保をつけます」。 https://t.co/CqE1l9Nate
一次予防でアスピリンを服用させる意味なんてあるの?、って常々思っていたけど、これではっきりとしたのかもしれません。
Effect of Aspirin on Disability-free Survival in the Healthy Elderly | NEJM https://t.co/Dd3NW3wijJ
RT @docrhall: Whoa!!!! 😮 https://t.co/smotoBqi1T
RT @EricTopol: When low-dose aspirin is not only a bust, but is associated with higher all-cause mortality, #cancer, and more bleeding in h…
RT @Steph_Achenbach: 3rd recent “Nail in the Coffin“ for aspirin in primary prevention? After ARRIVE in 12 546 moderate risk individuals, A…
RT @DrNaifAlJohani: تناول حبة اسبرين لكبار السن [بدون وجود سبب مبرر لذلك كجلطة سابقة] مضرة . #اطباء_العالم #صوت_الطبيب https://t.co/fYk3…
RT @ryoma_tanaka: アスピリンについてのスタディーが3つNEJMに発表されましたね。 出血が増えて悪性疾患が増えて心血管疾患は減らなくて、死亡リスクは増えるという何だか大変な結果になっています。 https://t.co/tdsfmj8miC https://t…
RT @ryoma_tanaka: アスピリンについてのスタディーが3つNEJMに発表されましたね。 出血が増えて悪性疾患が増えて心血管疾患は減らなくて、死亡リスクは増えるという何だか大変な結果になっています。 https://t.co/tdsfmj8miC https://t…
RT @ryoma_tanaka: アスピリンについてのスタディーが3つNEJMに発表されましたね。 出血が増えて悪性疾患が増えて心血管疾患は減らなくて、死亡リスクは増えるという何だか大変な結果になっています。 https://t.co/tdsfmj8miC https://t…
RT @garryjennings: Effect of Aspirin on Disability-free Survival in the Healthy Elderly | NEJM https://t.co/E43ypsNUAa Congratulations John…
@MelHerbert How about this one on ASA? https://t.co/nvOlLagv6p
RT @martinezvelilla: Effect of Aspirin on Disability-free Survival in the Healthy Elderly | NEJM : Aspirin use in healthy elderly persons d…
RT @ryoma_tanaka: アスピリンについてのスタディーが3つNEJMに発表されましたね。 出血が増えて悪性疾患が増えて心血管疾患は減らなくて、死亡リスクは増えるという何だか大変な結果になっています。 https://t.co/tdsfmj8miC https://t…
バイアスピリンを服用中なのでドキッとしました😱
RT @ryoma_tanaka: アスピリンについてのスタディーが3つNEJMに発表されましたね。 出血が増えて悪性疾患が増えて心血管疾患は減らなくて、死亡リスクは増えるという何だか大変な結果になっています。 https://t.co/tdsfmj8miC https://t…
Aspirin not beneficial in older people in the absence of heart disease, vascular disease or stroke. Study shows :https://t.co/59bibYPtuW
RT @EricTopol: When low-dose aspirin is not only a bust, but is associated with higher all-cause mortality, #cancer, and more bleeding in h…
New study @NEJM shows why for a long time there's been a need to establish appropriate criteria for when #healthy-people — #elderly people — need #aspirin @AGE @ASAging #aging https://t.co/ybRnqxw46Q
RT @ryoma_tanaka: アスピリンについてのスタディーが3つNEJMに発表されましたね。 出血が増えて悪性疾患が増えて心血管疾患は減らなくて、死亡リスクは増えるという何だか大変な結果になっています。 https://t.co/tdsfmj8miC https://t…
Primary prevention with 100mg Aspirin does not decrease cardiovascular disease but rather promotes hemorrhage https://t.co/Ceuc7Tod0h low-dose aspirin as a primary prevention strategy in older ppl resulted in a significantly higher risk of major hemorrhage
RT @EricTopol: When low-dose aspirin is not only a bust, but is associated with higher all-cause mortality, #cancer, and more bleeding in h…
RT @ryoma_tanaka: アスピリンについてのスタディーが3つNEJMに発表されましたね。 出血が増えて悪性疾患が増えて心血管疾患は減らなくて、死亡リスクは増えるという何だか大変な結果になっています。 https://t.co/tdsfmj8miC https://t…
RT @ryoma_tanaka: アスピリンについてのスタディーが3つNEJMに発表されましたね。 出血が増えて悪性疾患が増えて心血管疾患は減らなくて、死亡リスクは増えるという何だか大変な結果になっています。 https://t.co/tdsfmj8miC https://t…
RT @elliott_rohan: Low-dose aspirin in healthy older people had no effect on survival, physical disability or risk of dementia in this larg…
RT @ryoma_tanaka: アスピリンについてのスタディーが3つNEJMに発表されましたね。 出血が増えて悪性疾患が増えて心血管疾患は減らなくて、死亡リスクは増えるという何だか大変な結果になっています。 https://t.co/tdsfmj8miC https://t…
RT @IntraMednet: Effect of Aspirin on Disability-free Survival in the Healthy Elderly. https://t.co/b2e3T2ZeUm https://t.co/5obZUtBk3N
No benefit for ASA in healthy elderly ASPREE investigators https://t.co/YIhJpq5fbT
RT @ryoma_tanaka: アスピリンについてのスタディーが3つNEJMに発表されましたね。 出血が増えて悪性疾患が増えて心血管疾患は減らなくて、死亡リスクは増えるという何だか大変な結果になっています。 https://t.co/tdsfmj8miC https://t…
RT @ryoma_tanaka: アスピリンについてのスタディーが3つNEJMに発表されましたね。 出血が増えて悪性疾患が増えて心血管疾患は減らなくて、死亡リスクは増えるという何だか大変な結果になっています。 https://t.co/tdsfmj8miC https://t…
RT @Steph_Achenbach: 3rd recent “Nail in the Coffin“ for aspirin in primary prevention? After ARRIVE in 12 546 moderate risk individuals, A…
RT @ryoma_tanaka: アスピリンについてのスタディーが3つNEJMに発表されましたね。 出血が増えて悪性疾患が増えて心血管疾患は減らなくて、死亡リスクは増えるという何だか大変な結果になっています。 https://t.co/tdsfmj8miC https://t…
RT @ryoma_tanaka: アスピリンについてのスタディーが3つNEJMに発表されましたね。 出血が増えて悪性疾患が増えて心血管疾患は減らなくて、死亡リスクは増えるという何だか大変な結果になっています。 https://t.co/tdsfmj8miC https://t…
RT @Retweeterstein: We always like sharing gear we think could save your life! https://t.co/lPHgLLEO0I #survival #prepper #preppers #outd…
RT @EricTopol: When low-dose aspirin is not only a bust, but is associated with higher all-cause mortality, #cancer, and more bleeding in h…
Effect of Aspirin on Disability-free Survival in the Healthy Elderly | NEJM https://t.co/jDLCfqW06S
We always like sharing gear we think could save your life! https://t.co/lPHgLLEO0I #survival #prepper #preppers #outdoors
RT @ryoma_tanaka: アスピリンについてのスタディーが3つNEJMに発表されましたね。 出血が増えて悪性疾患が増えて心血管疾患は減らなくて、死亡リスクは増えるという何だか大変な結果になっています。 https://t.co/tdsfmj8miC https://t…
RT @EricTopol: When low-dose aspirin is not only a bust, but is associated with higher all-cause mortality, #cancer, and more bleeding in h…
RT @EricTopol: When low-dose aspirin is not only a bust, but is associated with higher all-cause mortality, #cancer, and more bleeding in h…
RT @redGDPS: Effect of Aspirin on Disability-free Survival in the Healthy Elderly https://t.co/EEMFodudBR Aspirin use in healthy elderly p…
RT @Gill_Livingston: Great trial. Huge numbers, long follow up and small loss. Low dose aspirin in healthy older people does not reduce sub…
Very interesting study.... https://t.co/x545MnFmgN
RT @Gill_Livingston: Great trial. Huge numbers, long follow up and small loss. Low dose aspirin in healthy older people does not reduce sub…
RT @IHamamsy: This is a real shocker and challenges long-held dogmas about Aspirin. Kudos to the research teams for scientifically challeng…
RT @EricTopol: When low-dose aspirin is not only a bust, but is associated with higher all-cause mortality, #cancer, and more bleeding in h…
RT @Gill_Livingston: Great trial. Huge numbers, long follow up and small loss. Low dose aspirin in healthy older people does not reduce sub…
Effect of Aspirin on Disability-free Survival in the Healthy Elderly | NEJM https://t.co/bGixjwrfXS
Es la misma gata, pero con diferente DOI Gracias por recordarnos la utilidad de la aspirina. https://t.co/3uS9cjKRCX
RT @EricTopol: When low-dose aspirin is not only a bust, but is associated with higher all-cause mortality, #cancer, and more bleeding in h…
RT @JamesPickett12: 5 years of low dose aspirin showed no beneficial effect on dementia in >70s (or any effect on other beneficial outcomes…
RT @EricTopol: When low-dose aspirin is not only a bust, but is associated with higher all-cause mortality, #cancer, and more bleeding in h…
RT @EricTopol: When low-dose aspirin is not only a bust, but is associated with higher all-cause mortality, #cancer, and more bleeding in h…
RT @hhrinstitute: Effect of Aspirin on Disability-free Survival in the Healthy Elderly | NEJM https://t.co/aafBDia2Wh
RT @JamesPickett12: 5 years of low dose aspirin showed no beneficial effect on dementia in >70s (or any effect on other beneficial outcomes…
RT @EricTopol: When low-dose aspirin is not only a bust, but is associated with higher all-cause mortality, #cancer, and more bleeding in h…
RT @StephenPiment: Effect of Aspirin on Disability-free Survival in the Healthy Elderly https://t.co/OK76Zuch08
Effect of Aspirin on Disability-free Survival in the Healthy Elderly https://t.co/OK76Zuch08
RT @EricTopol: When low-dose aspirin is not only a bust, but is associated with higher all-cause mortality, #cancer, and more bleeding in h…
@TrialmethodsUCC For discussion https://t.co/sqHUuR5iv4 #EH6124
RT @Steph_Achenbach: 3rd recent “Nail in the Coffin“ for aspirin in primary prevention? After ARRIVE in 12 546 moderate risk individuals, A…
RT @Gill_Livingston: Great trial. Huge numbers, long follow up and small loss. Low dose aspirin in healthy older people does not reduce sub…
RT @Gill_Livingston: Great trial. Huge numbers, long follow up and small loss. Low dose aspirin in healthy older people does not reduce sub…
Great trial. Huge numbers, long follow up and small loss. Low dose aspirin in healthy older people does not reduce subsequent disability, dementia or death. Really useful to know.
RT @eddeestyle: Daily ASA not for everyone, and definitely not harmless https://t.co/7X9z08uE9V
Heard this on @NPR today! Fascinating study! Alongside the NEJM article, the NIH's press release is worth reading: https://t.co/gVggZiwHuz …